Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.59%
#2 Venom Venom +24.69%
#3 Decred Decred +10.82%
#4 DexNet DexNet +7.57%
#5 TRIA TRIA +6.91%
#6 Status Status +6.45%
#7 Wibx Wibx +5.98%
#8 SkyAI SkyAI +5.16%
#9 Talus Network Talus Network +4.56%
#10 Audiera Audiera +4.30%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Finch Therapeutics Group, Inc. Finch Therapeutics Group, Inc.

Finch Therapeutics Group, Inc.

FNCH
Clasificación en acciones #30545
Finch Therapeutics is a microbiome technology company with a portfolio of... Finch Therapeutics is a microbiome technology company with a portfolio of intellectual property and microbiome assets. The company is now focused on realizing the value of its intellectual property estate and other assets, while supporting the advancement of its microbiome technology through partnerships and collaborations after winding down development efforts.
Precio por acción
$10.20
Última sincronización: 2026-08-05
Capitalización bursátil
$16.38M
Cambio (1 día)
2.00%
Cambio (1 año)
-18.40%
País
US
Comercio Finch Therapeutics Group, Inc. (FNCH)

Categoría

Healthcare
Historial del precio de la acción de Finch Therapeutics Group, Inc. (FNCH)
Precio más alto de cierre: $10.20 el 2026-08-01

Precio más bajo de cierre: $509.37 el 2021-03-01
Historial del precio de la acción de Finch Therapeutics Group, Inc. desde 2021 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -13.21%
2025 19.77%
2024 211.15%
2023 -82.69%
2022 -93.58%
2021 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.89 35.09%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $996.61 51.72%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $116.13 -20.22%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $735.86 6.07%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $257.75 14.92%
BE